BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Lisuride

An ergot derivative that acts as an agonist at dopamine D2 receptors (DOPAMINE AGONISTS). It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors (SEROTONIN RECEPTOR AGONISTS).

299+ PubMed studies analyzed · 22 RCTs · Evidence Score: 45.3

Research Domains

Lisuride has been studied across 18 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, 🧠 Neuroprotection, 💊 Pain, 😴 Sleep. The primary research focus is 🌤️ Mood & Depression with 58% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Lisuride, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Ergotamine
27 shared targets
Yohimbine
28 shared targets
Pergolide
28 shared targets
Dihydroergotamine
27 shared targets
Bromocriptine
30 shared targets
Quetiapine
26 shared targets
nantenine
20 shared targets
Oxymetazoline
19 shared targets
Trazodone
21 shared targets
brexpiprazole
22 shared targets
Loading evidence profile...

This evidence profile for Lisuride is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.